Chemoinformaics analysis of 4-Ethyl-2-methoxy-6-methylphenol
| Molecular Weight | 166.22 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
| Exact Molecular Weight | 166.099 | nRing | 1 |
| Solubility: LogS | -2.56 | nHRing | 0 |
| Solubility: LogP | 2.732 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 27.6391 |
| nHD | 1 | BPOL | 15.7809 |
| QED | 0.73 |
| Synth | 1.861 |
| Natural Product Likeliness | 0.414 |
| NR-PPAR-gamma | 0.381 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.324 |
| HIA | 0.004 |
| CACO-2 | -4.396 |
| MDCK | 0.0000242 |
| BBB | 0.553 |
| PPB | 0.9382 |
| VDSS | 1.695 |
| FU | 0.0381903 |
| CYP1A2-inh | 0.914 |
| CYP1A2-sub | 0.953 |
| CYP2c19-inh | 0.489 |
| CYP2c19-sub | 0.853 |
| CYP2c9-inh | 0.203 |
| CYP2c9-sub | 0.751 |
| CYP2d6-inh | 0.458 |
| CYP2d6-sub | 0.889 |
| CYP3a4-inh | 0.096 |
| CYP3a4-sub | 0.481 |
| CL | 13.343 |
| T12 | 0.864 |
| hERG | 0.028 |
| Ames | 0.016 |
| ROA | 0.056 |
| SkinSen | 0.933 |
| Carcinogencity | 0.198 |
| EI | 0.983 |
| Respiratory | 0.193 |
| NR-Aromatase | 0.087 |
| Antiviral | No |
| Prediction | 0.879647 |